Zhenfeng Zhang

1.0k total citations
18 papers, 818 citations indexed

About

Zhenfeng Zhang is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Zhenfeng Zhang has authored 18 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Zhenfeng Zhang's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Protein Degradation and Inhibitors (4 papers). Zhenfeng Zhang is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Protein Degradation and Inhibitors (4 papers). Zhenfeng Zhang collaborates with scholars based in China, United States and Hong Kong. Zhenfeng Zhang's co-authors include Balázs Halmos, Titus J. Boggon, Susumu Kobayashi, Amy L. Stiegler, Ying Jing, Guanglei Zhuang, Pengfei Ma, Jinjun Li, Ming Yao and Xianghuo He and has published in prestigious journals such as Hepatology, Oncogene and Scientific Reports.

In The Last Decade

Zhenfeng Zhang

18 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenfeng Zhang China 11 596 317 205 131 90 18 818
Hugues Ripoche France 14 653 1.1× 307 1.0× 226 1.1× 108 0.8× 89 1.0× 20 992
Mamunur Rashid United Kingdom 14 491 0.8× 220 0.7× 248 1.2× 89 0.7× 67 0.7× 19 817
Bernard Leroy France 10 453 0.8× 287 0.9× 396 1.9× 89 0.7× 37 0.4× 10 747
Renaud Grépin France 16 601 1.0× 278 0.9× 278 1.4× 154 1.2× 47 0.5× 26 917
Ming Quan China 18 584 1.0× 264 0.8× 200 1.0× 101 0.8× 55 0.6× 37 799
Yeonjoo Jung South Korea 18 689 1.2× 182 0.6× 241 1.2× 156 1.2× 76 0.8× 26 953
Saori Fujiwara Japan 18 492 0.8× 384 1.2× 268 1.3× 122 0.9× 60 0.7× 34 845
Rosanna Lacalamita Italy 15 358 0.6× 233 0.7× 223 1.1× 97 0.7× 56 0.6× 30 647
Alice Faversani Italy 15 644 1.1× 419 1.3× 262 1.3× 113 0.9× 96 1.1× 20 1.0k

Countries citing papers authored by Zhenfeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Zhenfeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenfeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenfeng Zhang more than expected).

Fields of papers citing papers by Zhenfeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenfeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenfeng Zhang. The network helps show where Zhenfeng Zhang may publish in the future.

Co-authorship network of co-authors of Zhenfeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenfeng Zhang. A scholar is included among the top collaborators of Zhenfeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenfeng Zhang. Zhenfeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Cheng, Jizhou Gou, Yixuan Cai, et al.. (2024). Deciphering lung granulomas in HIV & TB co-infection: unveiling macrophages aggregation with IL6R/STAT3 activation. Emerging Microbes & Infections. 13(1). 2366359–2366359. 4 indexed citations
2.
Xiang, Huaijiang, Zhenfeng Zhang, Mei‐Chun Cai, et al.. (2023). Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer. Science Advances. 9(47). eadj0123–eadj0123. 9 indexed citations
3.
Zhang, Zhenfeng, Ke Zhang, Yuxia Liu, et al.. (2021). Epigenetic heterogeneity promotes acquired resistance to BET bromodomain inhibition in ovarian cancer.. American Journal of Cancer Research. 11(6). 3021–3038. 4 indexed citations
4.
Jing, Ying, Yi Zhang, Hui Zhu, et al.. (2019). Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer. Oncogene. 38(16). 3047–3060. 6 indexed citations
5.
Zhang, Zhenfeng. (2018). Summary of Primary Culture of Human Lung Cancer Cells. 5(1). 1 indexed citations
6.
Zhang, Zhenfeng, Huixin Peng, Xiaojie Wang, et al.. (2017). Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer. Molecular Cancer Therapeutics. 16(9). 1739–1750. 58 indexed citations
7.
Wu, Xiaoliang, Zhongwen Li, Ling Gu, et al.. (2017). NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma. Oncology Research and Treatment. 40(6). 370–374. 40 indexed citations
8.
Deng, Chuangzhong, Jieping Chen, Shengjie Guo, et al.. (2017). CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression. World Journal of Urology. 35(8). 1213–1221. 6 indexed citations
9.
Yin, Xia, Xiaojie Wang, Ying Jing, et al.. (2016). A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis. Scientific Reports. 6(1). 31079–31079. 15 indexed citations
10.
Jing, Ying, Zhenfeng Zhang, Pengfei Ma, et al.. (2015). Concomitant BET and MAPK blockade for effective treatment of ovarian cancer. Oncotarget. 7(3). 2545–2554. 31 indexed citations
11.
Cheng, Haiying, Zhenfeng Zhang, Ruth Rodríguez‐Barrueco, et al.. (2015). Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells. Oncotarget. 7(20). 28976–28988. 78 indexed citations
12.
Cai, Peiqiang, et al.. (2015). Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment. Chinese Journal of Cancer. 34(3). 130–6. 8 indexed citations
13.
Zhang, Zhenfeng, Pengfei Ma, Ying Jing, et al.. (2015). BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1. Theranostics. 6(2). 219–230. 81 indexed citations
14.
Huang, Zhaohui, Pushuai Wen, Ruirui Kong, et al.. (2014). USP33 mediates Slit‐Robo signaling in inhibiting colorectal cancer cell migration. International Journal of Cancer. 136(8). 1792–1802. 51 indexed citations
15.
16.
Jing, Ying, Deshui Jia, Chun‐Ming Wong, et al.. (2013). SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma. Molecular Oncology. 8(2). 366–377. 35 indexed citations
17.
Zhang, Zhenfeng, Amy L. Stiegler, Titus J. Boggon, Susumu Kobayashi, & Balázs Halmos. (2010). EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget. 1(7). 497–514. 158 indexed citations
18.
Yao, Jian, Linhui Liang, Shenglin Huang, et al.. (2009). Microrna-30D Promotes Tumor Invasion and Metastasis by Targeting Galphai2 in Hepatocellular Carcinoma. Hepatology. 51(3). 846–856. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugues Ripoche Breakdown of academic impact, for papers by Mamunur Rashid Breakdown of academic impact, for papers by Bernard Leroy Breakdown of academic impact, for papers by Renaud Grépin Breakdown of academic impact, for papers by Ming Quan Breakdown of academic impact, for papers by Yeonjoo Jung Breakdown of academic impact, for papers by Saori Fujiwara Breakdown of academic impact, for papers by Rosanna Lacalamita Breakdown of academic impact, for papers by Alice Faversani
Rankless by CCL
2026